⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WLDN News
Willdan Group, Inc.
Form 8-K
sec.gov
WLDN
Willdan to Acquire Mantis Innovation, Strengthening Its Position in Energy Management and Infrastructure
businesswire.com
WLDN
Walden Biosciences Announces CMO Appointment and Upcoming Clinical Data for WAL0921 in Proteinuric Chronic Kidney Disease
globenewswire.com
WLDN
Form 8-K
sec.gov
WLDN
Willdan Selected by Encina Wastewater Authority for $31 Million Cogeneration Project
businesswire.com
WLDN
Willdan Announces Date of Second Quarter 2026 Earnings Release and Conference Call
businesswire.com
WLDN
Croma-Pharma annonce l'approbation par la FDA de l'Obagi saypha® ChIQ™ aux États-Unis
businesswire.com
WLDN
Croma-Pharma gibt die Zulassung von Obagi saypha® ChIQ™ durch die FDA in den Vereinigten Staaten bekannt
businesswire.com
WLDN
Croma-Pharma annuncia che la FDA ha approvato l'uso di Obagi saypha® ChIQ™ negli Stati Uniti
businesswire.com
WLDN
Form 8-K
sec.gov
WLDN